Filing Flows › Maravai Lifesciences Holdings (MRVI) › How it makes money
How Maravai Lifesciences Holdings (MRVI) makes money
Maravai Lifesciences Holdings (MRVI) made $45.9M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. TriLink brought in $28.4M (62%); Cygnus brought in $17.5M (38%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| TriLink | $28.4M | 61.8% | -18% | +12% |
| Cygnus | $17.5M | 38.2% | +4% | +8% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $45.9M | 100.0% |
| Operating cash flow | $5.0M | 10.9% |
| Free cash flow | $4.5M | 9.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $45.9M | +10% |
| Q2 2026 | $51.4M | +8% |
| Q1 2026 | $65.8M | +40% |
| Q4 2025 | $49.9M | -12% |
| Q3 2025 | $41.6M | -40% |
| Q2 2025 | $47.4M | -32% |
| Q1 2025 | $46.9M | -27% |
From Maravai Lifesciences Holdings' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Maravai Lifesciences Holdings make money?
Maravai Lifesciences Holdings (MRVI) made $45.9M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. TriLink brought in $28.4M (62%); Cygnus brought in $17.5M (38%).
What is Maravai Lifesciences Holdings' biggest business?
TriLink: $28.4M in the third quarter 2026, 62% of revenue, +12% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.